Home

Elektrisch Glaubensbekenntnis Verbannung rich evans diabetes Andernfalls Panel Steifigkeit

Nutrients | Free Full-Text | Carbohydrate Restriction in Type 1 Diabetes: A  Realistic Therapy for Improved Glycaemic Control and Athletic Performance?
Nutrients | Free Full-Text | Carbohydrate Restriction in Type 1 Diabetes: A Realistic Therapy for Improved Glycaemic Control and Athletic Performance?

Elizabeth Evans Hughes—surviving starvation therapy for diabetes - The  Lancet
Elizabeth Evans Hughes—surviving starvation therapy for diabetes - The Lancet

Continuous Glucose Monitoring (CGM) | FreeStyle Libre (CGM) systems
Continuous Glucose Monitoring (CGM) | FreeStyle Libre (CGM) systems

Type 2 Diabetes Mellitus: Practice Essentials, Background, Pathophysiology
Type 2 Diabetes Mellitus: Practice Essentials, Background, Pathophysiology

Antioxidants | Free Full-Text | Diabetes and Alzheimer's Disease: Might  Mitochondrial Dysfunction Help Deciphering the Common Path?
Antioxidants | Free Full-Text | Diabetes and Alzheimer's Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?

Prevalence, trends and associated factors of hypertension and diabetes  mellitus in Bangladesh: Evidence from BHDS 2011 and 2017–18 | PLOS ONE
Prevalence, trends and associated factors of hypertension and diabetes mellitus in Bangladesh: Evidence from BHDS 2011 and 2017–18 | PLOS ONE

Ronald Evans, PhD - Salk Institute for Biological Studies
Ronald Evans, PhD - Salk Institute for Biological Studies

Frontiers | Early Nutrition and Risk of Type 1 Diabetes: The Role of Gut  Microbiota
Frontiers | Early Nutrition and Risk of Type 1 Diabetes: The Role of Gut Microbiota

Consensus Statement by the American Association of Clinical  Endocrinologists and American College of Endocrinology on the Comprehensive  Type 2 Diabetes Management Algorithm – 2020 Executive Summary - Endocrine  Practice
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary - Endocrine Practice

IJMS | Free Full-Text | Whole Alga, Algal Extracts, and Compounds as  Ingredients of Functional Foods: Composition and Action Mechanism  Relationships in the Prevention and Treatment of Type-2 Diabetes Mellitus
IJMS | Free Full-Text | Whole Alga, Algal Extracts, and Compounds as Ingredients of Functional Foods: Composition and Action Mechanism Relationships in the Prevention and Treatment of Type-2 Diabetes Mellitus

Sensors | Free Full-Text | Artificial Intelligence in Decision Support  Systems for Type 1 Diabetes
Sensors | Free Full-Text | Artificial Intelligence in Decision Support Systems for Type 1 Diabetes

JCM | Free Full-Text | Sugar-Lowering Drugs for Type 2 Diabetes Mellitus  and Metabolic Syndrome—Strategies for In Vivo Administration: Part-II
JCM | Free Full-Text | Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Strategies for In Vivo Administration: Part-II

Cells | Free Full-Text | Role of c-Jun N-terminal Kinase (JNK) in Obesity  and Type 2 Diabetes
Cells | Free Full-Text | Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes

Processes | Free Full-Text | An Overview of the Potential of Medicinal  Plants Used in the Development of Nutraceuticals for the Management of  Diabetes Mellitus: Proposed Biological Mechanisms
Processes | Free Full-Text | An Overview of the Potential of Medicinal Plants Used in the Development of Nutraceuticals for the Management of Diabetes Mellitus: Proposed Biological Mechanisms

Frontiers | Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus
Frontiers | Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus

Diabetes
Diabetes

Proven clinical outcomes for insulin users - FreeStyle Libre
Proven clinical outcomes for insulin users - FreeStyle Libre

JCM | Free Full-Text | Plasma C-Peptide and Risk of Developing Type 2  Diabetes in the General Population
JCM | Free Full-Text | Plasma C-Peptide and Risk of Developing Type 2 Diabetes in the General Population

New Perspectives into the Molecular Pathogenesis and Treatment of Type 2  Diabetes: Cell
New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes: Cell

Heart Failure in Type 2 Diabetes Mellitus | Circulation Research
Heart Failure in Type 2 Diabetes Mellitus | Circulation Research

Diabetes in numbers | Nature
Diabetes in numbers | Nature

Maternal Obesity and Diabetes Mellitus as Risk Factors for Congenital Heart  Disease in the Offspring | Journal of the American Heart Association
Maternal Obesity and Diabetes Mellitus as Risk Factors for Congenital Heart Disease in the Offspring | Journal of the American Heart Association

Nutrients | Free Full-Text | Shared Neuropathological Characteristics of  Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive  Decline
Nutrients | Free Full-Text | Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline

Gene expression signatures of target tissues in type 1 diabetes, lupus  erythematosus, multiple sclerosis, and rheumatoid arthritis | Science  Advances
Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis | Science Advances

Frontiers | Vascular Dysfunction in Diabetes and Obesity: Focus on TRP  Channels
Frontiers | Vascular Dysfunction in Diabetes and Obesity: Focus on TRP Channels